These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10439681)

  • 1. [Torsades de pointes during treatment of leishmaniasis with meglumine antimoniate].
    Castelló Viguer MT; Echánove Errazti I; Ridocci Soriano F; Esteban Esteban E; Atienza Fernández F; Cuesta Estellés G
    Rev Esp Cardiol; 1999 Jul; 52(7):533-5. PubMed ID: 10439681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentavalent antimonial-induced torsade de pointes.
    Ortega-Carnicer J; Alcázar R; De la Torre M; Benezet J
    J Electrocardiol; 1997 Apr; 30(2):143-5. PubMed ID: 9141610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meglumine antimoniate, amiodarone and torsades de pointes: a case report.
    Segura I; García-Bolao I
    Resuscitation; 1999 Sep; 42(1):65-8. PubMed ID: 10524732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pancreatitis during treatment of leishmaniasis with n-methylglucamine antimoniate in a subject infected with HIV].
    Trinchieri V; Ferone U; Monacelli M; Isceri L; Proietti F; Sorice F
    Riv Eur Sci Med Farmacol; 1996; 18(2):49-51. PubMed ID: 9213843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Torsade de pointes secondary to treatment with pentavalent antimonial drugs].
    Temprano Vázquez S; García Salazar MA; Jiménez Martín MJ; López Martínez J
    Med Clin (Barc); 1998 May; 110(18):717. PubMed ID: 9656226
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
    de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
    Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe arthralgia, not related to dose, associated with pentavalent antimonial therapy for mucosal leishmaniasis.
    Castro C; Sampaio RN; Marsden PD
    Trans R Soc Trop Med Hyg; 1990; 84(3):362. PubMed ID: 2260169
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytogenetic observations after meglumine antimoniate therapy for visceral leishmaniasis.
    Hantson P; Léonard ED; Crutzen-Fayt MC; Léonard A; Vandercam B; Delaere B; Mahieu P
    Pharmacotherapy; 1996; 16(5):869-71. PubMed ID: 8888081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe leucopenia during treatment of visceral leishmaniasis.
    Hiçsönmez G; Jama H; Ozsoylu S
    Trans R Soc Trop Med Hyg; 1988; 82(3):417. PubMed ID: 3232176
    [No Abstract]   [Full Text] [Related]  

  • 10. [A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety].
    Saldanha AC; Romero GA; Merchan-Hamann E; Magalhães AV; Macedo Vde O
    Rev Soc Bras Med Trop; 1999; 32(4):383-7. PubMed ID: 10495667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Meglumine Antimoniate in Cutaneous Leishmaniasis of Children: Clinical and Laboratory Complications.
    Layegh P; Khademi Z; Afzal Aghaee M; Moghiman T
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):356-8. PubMed ID: 26582874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meglumine antimoniate-induced pancreatitis.
    Torrús D; Massa B; Boix V; Portilla J; Pérez-Mateo M
    Am J Gastroenterol; 1996 Apr; 91(4):820-1. PubMed ID: 8677970
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
    Kuyucu N; Kara C; Bakirtaç A; Teziç T
    Pediatr Infect Dis J; 2001 Apr; 20(4):455-7. PubMed ID: 11332679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala.
    Navin TR; Arana BA; Arana FE; de Mérida AM; Castillo AL; Pozuelos JL
    Am J Trop Med Hyg; 1990 Jan; 42(1):43-50. PubMed ID: 2405727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Symptomatic hypokalemia caused by meglumine antimoniate].
    Bouvresse S; Matichard E; Mahé E; Marinho E; Soria A; Devillière M; Descamps V; Crickx B
    Ann Dermatol Venereol; 2007 Apr; 134(4 Pt 1):387-8. PubMed ID: 17483764
    [No Abstract]   [Full Text] [Related]  

  • 16. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
    Delgado J; Macías J; Pineda JA; Corzo JE; González-Moreno MP; de la Rosa R; Sánchez-Quijano A; Leal M; Lissen E
    Am J Trop Med Hyg; 1999 Nov; 61(5):766-9. PubMed ID: 10586909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
    Barthet M; Brunet P; Bernard JC; Dussol B; Rodor F; Jouglard J; Berland Y; Sahel J
    Gastroenterol Clin Biol; 1994; 18(1):90-2. PubMed ID: 8187998
    [No Abstract]   [Full Text] [Related]  

  • 18. [Meglumine antimoniate].
    Silva JB
    Rev Soc Bras Med Trop; 2001; 34(1):103-5. PubMed ID: 11340506
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimony containing drug and ECG abnormalities in children with visceral leishmaniasis.
    Zanoni LZ; Brustoloni YM; Melnikov P; Cônsolo CE
    Biol Trace Elem Res; 2009 Dec; 132(1-3):35-40. PubMed ID: 19424667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
    Laguna F; López-Vélez R; Pulido F; Salas A; Torre-Cisneros J; Torres E; Medrano FJ; Sanz J; Picó G; Gómez-Rodrigo J; Pasquau J; Alvar J
    AIDS; 1999 Jun; 13(9):1063-9. PubMed ID: 10397536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.